Health / Medical Topics

    Hu14.18-interleukin-2 fusion protein

    Pronunciation

    An anticancer drug in which hu14.18, a monoclonal antibody, is combined with interleukin-2. The monoclonal antibody binds to the cancer cells and delivers IL-2, which stimulates the immune system to destroy the cancer cells. (NCI Dictionary)




    YOU MAY ALSO LIKE

    A recombinant protein consisting of the hu14.18 monoclonal antibody fused to the cytokine interleukin-2 (IL2) with potential antineoplastic activity. The monoclonal antibody…
    A DNA-binding and thermostable low-molecular-weight E. coli protein that resembles eukaryotic histones. Acts as a cofactor in transcriptional repression. (from IRB…
    Human HTT wild-type allele is located in the vicinity of 4p16.3 and is approximately 199 kb in length. This allele, which encodes…
    This gene may be involved in vesicle transport.
    Human HTRA1 wild-type allele is located in the vicinity of 10q26.3 and is approximately 53 kb in length. This allele, which encodes…
    This gene plays a role in proteolysis.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact